Nective Forte (Inactivated Water in Oil Emulsion Vaccine)

Indications

• Hydration therapy
• Solvent for intravenous medications
• Diluent for oral medications
• Rehydration in cases of fluid loss
• Topical applications for wound care

Dosage

Children: Refer to specific drug formulations for appropriate dosing, as the dosage will vary depending on the active ingredient in the aqueous solution.

Adults: Refer to specific drug formulations for appropriate dosing, as the dosage will vary depending on the active ingredient in the aqueous solution.

Mechanism of action

Aqueous solutions serve primarily as a medium for drug solubility and absorption. The mechanism of action depends on the active ingredient dissolved within the aqueous solution. For many drugs, the aqueous environment enhances bioavailability by allowing the active ingredients to dissolve and interact with biological membranes, facilitating their transport across cell barriers.

Pharmacodynamics

The pharmacodynamics of aqueous solutions are influenced by the solutes they contain. Generally, the dissolution of drugs in an aqueous medium can enhance their effectiveness by improving absorption rates, increasing peak plasma concentrations, and allowing for more predictable pharmacological effects. The specific pharmacodynamic response will depend on the nature of the solute and its interaction with the body’s receptors or enzymes.

Pharmacokinetics

The pharmacokinetics of aqueous solutions largely pertain to the dissolved substances. They are absorbed through various routes, such as gastrointestinal tract, intravenous administration, or topical application, depending on the formulation. The rate of absorption can vary based on the solute’s properties, such as molecular weight, lipophilicity, and the presence of other excipients. Distribution, metabolism, and excretion will also depend on the active ingredient within the aqueous solution.

Pregnancy

Aqueous solutions are generally regarded as safe for use during pregnancy, but the specific context and formulation should be considered.

Breast-feeding

Aqueous solutions are typically considered safe during breastfeeding, but caution is advised depending on the specific formulation.

Storage

Store at room temperature, away from direct sunlight and moisture. Ensure containers are tightly sealed.

Formulations

• Aqueous solution
• Aqueous gel
• Aqueous suspension

Indications

• COVID-19
• SARS-CoV-2 infection

Dosage

Children: Refer to the BNF for Children for specific dosing recommendations in paediatric patients.

Adults: Refer to the BNF for specific dosing recommendations based on clinical guidelines.

Mechanism of action

Nirmatrelvir is a selective inhibitor of the SARS-CoV-2 main protease (Mpro). By binding to the active site of this enzyme, nirmatrelvir prevents the cleavage of viral polyproteins, which is essential for the maturation of the virus. This ultimately inhibits viral replication.

Pharmacodynamics

Nirmatrelvir exhibits antiviral activity by specifically targeting the main protease of SARS-CoV-2. The inhibition of Mpro disrupts the viral life cycle, reducing the viral load in the body. The potency of nirmatrelvir is enhanced by ritonavir, which prolongs its action by slowing its metabolism.

Pharmacokinetics

Nirmatrelvir is rapidly absorbed after oral administration. The bioavailability is increased when combined with ritonavir, which inhibits CYP3A4, the enzyme responsible for nirmatrelvir's metabolism. The half-life of nirmatrelvir is approximately 7 hours, allowing for twice-daily dosing. It is primarily excreted via feces and urine, with minimal renal clearance.

Interactions

• nirmatrelvir boosted with ritonavir and containing ethinylestradiol: Unknown (decreases concentration)

Indications

• Hepatitis A
• Hepatitis B
• Influenza
• Polio
• Rabies
• Typhoid fever

Dosage

Children: Refer to specific product guidelines for paediatric dosing, as it varies by vaccine type and indication.

Adults: Refer to specific product guidelines for adult dosing, as it varies by vaccine type and indication.

Mechanism of action

Inactivated vaccines work by introducing a form of the pathogen that cannot cause disease into the body. This stimulates the immune system to produce antibodies and memory cells specific to the pathogen, allowing for a robust immune response upon future exposure. The immune system recognizes the inactivated pathogen as foreign, leading to the activation of T-cells and B-cells, which are crucial for long-term immunity.

Pharmacodynamics

The pharmacodynamics of inactivated vaccines involve the generation of an adaptive immune response. After vaccination, the body produces specific antibodies against the inactivated pathogen. The response typically includes both humoral immunity, characterized by antibody production, and cellular immunity, involving T-cell activation. The duration of immunity can vary, and booster doses may be required to maintain adequate protection.

Pharmacokinetics

Inactivated vaccines do not have a pharmacokinetic profile like traditional drugs since they do not enter systemic circulation in the same manner. Following administration, the vaccine components are taken up by antigen-presenting cells, which process and present the antigens to T-cells. The immune response is initiated locally at the site of injection and can be influenced by factors such as the route of administration and the presence of adjuvants that enhance the immune response.

Adverse effects

• Injection site reactions (pain, swelling, redness)
• Fever
• Fatigue
• Headache
• Myalgia
• Chills

Precautions

• Assess for allergies to vaccine components
• Monitor for allergic reactions post-administration
• Consider underlying health conditions that may affect immune response

Pregnancy

Inactivated vaccines are generally considered safe during pregnancy, but individual risk-benefit assessment is recommended.

Breast-feeding

Inactivated vaccines can be administered during breastfeeding without concern for adverse effects in the infant.

Storage

Store in a refrigerator at 2°C to 8°C. Do not freeze.

Formulations

• Inactivated viral vaccines
• Inactivated bacterial vaccines

Indications

• Schizophrenia
• Bipolar disorder
• Major depressive disorder (as an adjunct)
• Treatment-resistant depression
• Other psychotic disorders

Dosage

Children: Refer to the BNF for Children for age-specific dosing recommendations.

Adults: Refer to specific clinical guidelines and consider individual patient factors for appropriate dosing.

Mechanism of action

Phase acts primarily as a dopamine D2 receptor antagonist, which reduces dopaminergic transmission in the central nervous system. Additionally, it has effects on serotonin receptors, particularly the 5-HT2A receptor, which may contribute to its antipsychotic effects and help mitigate side effects associated with dopamine antagonism. This dual action helps balance neurotransmitter systems, thereby improving overall clinical outcomes in patients with psychotic disorders.

Pharmacodynamics

Phase has a complex pharmacodynamic profile, characterized by its ability to alter mood, perception, and behavior. The blockade of D2 receptors is linked to the reduction of positive symptoms of schizophrenia, such as hallucinations and delusions. The antagonism of serotonin receptors is associated with the alleviation of negative symptoms, such as social withdrawal and apathy. The therapeutic effects, alongside potential side effects, are closely related to the drug's receptor binding affinities and the resulting changes in neurotransmitter dynamics within the brain.

Pharmacokinetics

Phase is typically administered orally and demonstrates significant first-pass metabolism, resulting in variable bioavailability. Peak plasma concentrations are reached within several hours after administration. The drug is primarily metabolized in the liver via cytochrome P450 enzymes, with multiple metabolites contributing to its overall activity. Elimination occurs predominantly through renal excretion, with a half-life that allows for once or twice daily dosing in most cases. Factors such as age, liver function, and concomitant medications can influence its pharmacokinetic profile.

Pregnancy

The effects of phase during pregnancy are not well studied; caution is advised.

Breast-feeding

The effects of phase during breastfeeding are not well established; caution is advised.

Storage

Store in a cool, dry place away from direct sunlight.